[go: up one dir, main page]

AU2001271976A1 - Microspheres and adjuvants for dna vaccine delivery - Google Patents

Microspheres and adjuvants for dna vaccine delivery

Info

Publication number
AU2001271976A1
AU2001271976A1 AU2001271976A AU7197601A AU2001271976A1 AU 2001271976 A1 AU2001271976 A1 AU 2001271976A1 AU 2001271976 A AU2001271976 A AU 2001271976A AU 7197601 A AU7197601 A AU 7197601A AU 2001271976 A1 AU2001271976 A1 AU 2001271976A1
Authority
AU
Australia
Prior art keywords
microspheres
adjuvants
dna vaccine
vaccine delivery
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001271976A
Inventor
Tricia Cecil
Lawrence Evans
Mark E. Johnson
Sally Mossman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AU2001271976A1 publication Critical patent/AU2001271976A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001271976A 2000-07-07 2001-07-09 Microspheres and adjuvants for dna vaccine delivery Abandoned AU2001271976A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21660400P 2000-07-07 2000-07-07
US60216604 2000-07-07
PCT/US2001/021780 WO2002003961A1 (en) 2000-07-07 2001-07-09 Microspheres and adjuvants for dna vaccine delivery

Publications (1)

Publication Number Publication Date
AU2001271976A1 true AU2001271976A1 (en) 2002-01-21

Family

ID=22807736

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001271976A Abandoned AU2001271976A1 (en) 2000-07-07 2001-07-09 Microspheres and adjuvants for dna vaccine delivery

Country Status (6)

Country Link
US (2) US20020032165A1 (en)
EP (1) EP1299087A1 (en)
JP (1) JP2004502721A (en)
AU (1) AU2001271976A1 (en)
CA (1) CA2414926A1 (en)
WO (1) WO2002003961A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030139356A1 (en) * 2001-05-18 2003-07-24 Persing David H. Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
CA2452382A1 (en) 2001-07-10 2003-01-23 Corixa Corporation Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres
GB0201736D0 (en) * 2002-01-25 2002-03-13 Glaxo Group Ltd DNA dosage forms
AU2002240250A1 (en) * 2002-02-04 2003-09-09 Antigenics Inc. Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
US6923958B2 (en) 2002-03-02 2005-08-02 The Scripps Research Institute DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof
US7094410B2 (en) * 2002-03-02 2006-08-22 The Scripps Research Institute DNA vaccine against proliferating endothelial cells and methods of use thereof
AU2003266014B2 (en) * 2002-05-06 2009-05-14 Alnylam Pharmaceuticals, Inc. Methods for delivery of nucleic acids
GB0228689D0 (en) * 2002-12-09 2003-01-15 Elan Drug Delivery Ltd Compositions
US7053783B2 (en) 2002-12-18 2006-05-30 Biovigilant Systems, Inc. Pathogen detector system and method
EP2263687B1 (en) 2002-12-27 2015-03-25 Novartis Vaccines and Diagnostics, Inc. Immunogenic compositions containing phospholipid
WO2004100985A2 (en) * 2003-05-12 2004-11-25 University Of Florida Research Foundation, Inc. Materials and methods for immunizing against fiv infection
US7658927B2 (en) * 2003-05-12 2010-02-09 University Of Florida Research Foundation, Inc. Materials and methods for immunizing against FIV infection
SE527505C2 (en) * 2003-06-10 2006-03-28 Anna Imberg Composite materials and particles
JP4871868B2 (en) * 2004-07-30 2012-02-08 バイオヴィジラント システムズ インコーポレイテッド Pathogen and particulate detection system and detection method
US7738099B2 (en) * 2005-07-15 2010-06-15 Biovigilant Systems, Inc. Pathogen and particle detector system and method
US8628976B2 (en) * 2007-12-03 2014-01-14 Azbil BioVigilant, Inc. Method for the detection of biologic particle contamination
RU2409384C1 (en) * 2009-07-15 2011-01-20 Государственное научное учреждение Всероссийский научно-исследовательский институт ветеринарной вирусологии и микробиологии Method for producing microcapsules for dna delivery to macroorganism
CN104981236B (en) * 2012-09-27 2019-01-22 珠海圣美生物诊断技术有限公司 Irritant Sensitive Microparticles and Method of Use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5741590A (en) * 1989-05-04 1990-11-29 Southern Research Institute Improved encapsulation process and products therefrom
EP1837017A3 (en) * 1997-01-22 2009-12-23 Eisai Inc. Microparticles for delivery of nucleic acid
US6048551A (en) * 1997-03-27 2000-04-11 Hilfinger; John M. Microsphere encapsulation of gene transfer vectors
US6197229B1 (en) * 1997-12-12 2001-03-06 Massachusetts Institute Of Technology Method for high supercoiled DNA content microspheres
GB9810236D0 (en) * 1998-05-13 1998-07-08 Microbiological Res Authority Improvements relating to encapsulation of bioactive agents

Also Published As

Publication number Publication date
WO2002003961A1 (en) 2002-01-17
US20040009941A1 (en) 2004-01-15
EP1299087A1 (en) 2003-04-09
US20020032165A1 (en) 2002-03-14
JP2004502721A (en) 2004-01-29
CA2414926A1 (en) 2002-01-17
WO2002003961B1 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
AU5532601A (en) Targeted vaccine delivery systems
AU2001271976A1 (en) Microspheres and adjuvants for dna vaccine delivery
GB0020953D0 (en) Vaccine
HUP0301043A3 (en) Vaccine
IL155072A0 (en) Vaccine
MXPA03002453A (en) Use of immidazoquinolinamines as adjuvants in dna vaccination.
AU1591402A (en) Vaccine
IL189736A0 (en) Vaccine adjuvants
AU2002361559A1 (en) Anticancer vaccine and diganostic methods and reagents
GB0014288D0 (en) Vaccine
AU1738201A (en) Adjuvants for nucleic acid vaccines
AUPQ233799A0 (en) Recombinant sub-unit vaccine
GB0014845D0 (en) Vaccine
GB0026334D0 (en) Vaccine
AU4957800A (en) Vaccine against isa virus
GB0025694D0 (en) Vaccine
AU2001294880A1 (en) Non-replicative particulate vaccine delivery system and methods of making and using same
AU2002347346A1 (en) Dna vaccine
AU2002315309A1 (en) Vaccine against tuberculosis
AU2001288795A1 (en) Eia vaccine and diagnostic
GB0003082D0 (en) Vaccine
AU5084300A (en) New vaccine formulations - 1
AU2001266534A1 (en) Papillomavirus vaccine
GB0006693D0 (en) Vaccine
GB0015722D0 (en) Vaccine

Legal Events

Date Code Title Description
BG Complete specifications treated as provisional specifications, section 37

Ref document number: PR643001

Country of ref document: AU